Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: Preliminary results
Clinical Rheumatology, Volume 33, No. 5, Year 2014
Notification
URL copied to clipboard!
Description
The role of interleukin (IL)-23 in the pathogenesis of inflammatory bowel disease (IBD) remains unclear. The aim of this work was to study the serum level of IL-23 in IBD with and without arthritis and determine its relation to the subsets and clinical features of the disease. Thirty-seven patients with IBD including 11 with arthritis were included in the study with a mean age of 30.86±4.66 years. Twenty healthy subjects served as control. Seronegative spondyloarthropathy was present in 11 (29.73%) of the IBD patients; Crohn's disease (CD) was present in 23 and 14 had ulcerative colitis (UC). Serum level of IL-23 was measured in all patients and control by ELISA. IL-23 was significantly higher in IBD patients (46.24±27.19 pg/ml) compared to control (24.1±2.31 pg/ml) (p<0.0001) being higher in CD patients (52.57±32.78 pg/ml) compared to those with UC (35.86±6.41 pg/ml) (p=0.026). Furthermore, it was significantly higher in those with peripheral and/or axial arthritis (67.73±40.85 pg/ml) compared to patients without (37.15±10.37 pg/ml) (p=0.03). There was a tendency to a higher level in males (49.15±30.97 pg/ml) compared to females (38.4±9.54 pg/ml). Serum IL-23 is increased in IBD especially those with CD associated with arthritis and sacroiliitis. The IL-23 could be added to the biomarkers of development of arthritis in IBD patients. These results also confirm the findings of previous studies on the critical role played by IL-23 in the pathogenesis of IBDmaking it an important new therapeutic target for these patients. © Clinical Rheumatology 2014.
Authors & Co-Authors
A Gheita, Tamer
Egypt, Cairo
Faculty of Medicine
El-Gazzar, Iman Ibrahim
Egypt, Cairo
Faculty of Medicine
El-Fishawy, Hussein Saeed
Egypt, Cairo
Faculty of Medicine
Aboul-Ezz, Mohammed A.
Egypt, Giza
Theodor Bilharz Research Institute
Kenawy, Sanaa A.
Egypt, Cairo
Faculty of Pharmacy
Statistics
Citations: 44
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1007/s10067-013-2469-y
ISSN:
07703198
e-ISSN:
14349949
Participants Gender
Female